ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo
A liquid biopsy to detect circulating tumor DNA after surgery for stage 2 colon cancer reduces the use of chemotherapy without sacrificing recurrence-free survival.
Source: medscape.com
Stay updated with breaking news from Haystack Oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A liquid biopsy to detect circulating tumor DNA after surgery for stage 2 colon cancer reduces the use of chemotherapy without sacrificing recurrence-free survival.